Short answer
Alpha Teknova, Inc. (TKNO) filed its fiscal 2025 10-K annual report with the SEC on Mar 2, 2026. It reported revenue of $41M (+7.4% year over year) and net income of −$17M.
- Top risk flagged: Regulatory risk: compliance with Second Amended and Restated Credit Agreement net revenue covenant of $39.0M for 2025, minimum cash requirement $8.0M
FY2025 key financial metrics · XBRL
- Revenue
- $41M
- +7.4% YoY
- Net income
- −$17M
- +35.5% YoY
- Operating margin
- -41.9%
- +27.4 pp YoY
- Gross margin
- 33.2%
- +14.0 pp YoY
- EPS (diluted)
- −$0.32
- +43.9% YoY
- ROE
- -25.1%
- +7.4 pp YoY
- Operating cash flow
- −$9M
- +30.2% YoY
Source: XBRL data from the Alpha Teknova, Inc. (TKNO) FY2025 10-K on SEC EDGAR. USD.
Alpha Teknova, Inc. FY2025 10-K analysis
AI summary of each section, grounded in the filing text
Business Overview
- Core business model: Custom manufacturing of critical reagents for life sciences, supporting research to commercialization stages
- New emphasis on scaling operations with investment in a new warehouse and distribution facility to improve capacity and efficiency
- Strategic shift: Growth focus through targeted marketing, strategic partnerships, and expanded sales efforts to increase brand awareness and market presence
- Revenue $40.5M in 2025, up $2.8M (7.4%) from 2024; operating loss narrowed to $17.0M from $26.1M in prior year
- Entered $28.245M amended credit facility in March 2025, including $23.245M term loan and $5M working capital, with revenue and cash covenants
Risk Factors
- Regulatory risk: compliance with Second Amended and Restated Credit Agreement net revenue covenant of $39.0M for 2025, minimum cash requirement $8.0M
- Macroeconomic exposure: 94.4% of revenue from U.S. customers, limited international diversification with only $2.3M (5.6%) sales outside U.S. in 2025
- Operational risk: reliance on manufacturing efficiency gains to improve gross margin to 33.2% in 2025 from 26.5% adjusted in 2024
- Competitive risk: reduced R&D spend by 20.4% to $2.2M in 2025 vs $2.8M in 2024, potentially impacting innovation versus peers
- Financial risk: $13.2M outstanding term loan with related $1.1M exit fee and total accumulated deficit of $135.8M as of December 31, 2025
Generated from the filing text; verify against the original. How to read a 10-K
Ask about this 10-K
Compare years, dig into a risk factor or check the numbers against insider trades and fund holders.